BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14688474)

  • 21. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
    Hu Y; Bally M; Dragowska WH; Mayer L
    Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
    Ye J; Li A; Liu Q; Wang X; Zhou J
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1042-8. PubMed ID: 16445569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel cytotoxicity is enhanced by inhibition of the Raf/MEK/ERK signal transduction pathway.
    Navolanic PM; Lee JT; McCubrey JA
    Cancer Biol Ther; 2003; 2(6):677-8. PubMed ID: 14688475
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
    Zhang L; Himi T; Morita I; Murota S
    Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
    MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
    Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
    J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
    Muenchen HJ; Poncza PJ; Pienta KJ
    Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
    Chou TC; Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1996; 37(3):222-8. PubMed ID: 8529281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
    Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
    Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.
    Qiao L; Studer E; Leach K; McKinstry R; Gupta S; Decker R; Kukreja R; Valerie K; Nagarkatti P; El Deiry W; Molkentin J; Schmidt-Ullrich R; Fisher PB; Grant S; Hylemon PB; Dent P
    Mol Biol Cell; 2001 Sep; 12(9):2629-45. PubMed ID: 11553704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
    Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.
    Yang CP; Horwitz SB
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):76-83. PubMed ID: 12063170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C; Wang S; Dent P; Grant S
    Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere).
    Menendez JA; Lupu R; Colomer R
    Breast Cancer Res Treat; 2004 Mar; 84(2):183-95. PubMed ID: 14999148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enhancement of FG020326 on sensitivity of MCF-7/ADR cells to taxotere via enhancing activation of caspase-8 and caspase-3].
    Wang XW; Ding Y; Liang YJ; Chen LM; Shi Z; Yang XP; Gu LQ; Fu LW
    Ai Zheng; 2004 Nov; 23(11 Suppl):1379-85. PubMed ID: 15566641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
    Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
    Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.